Closeout Retail

搜索文档
Kenorland Announces Termination of Joint Venture at the Healy Project, Alaska and Completes Top-Up Right from Sumitomo and Centerra
Newsfile· 2025-06-27 19:30
Kenorland Announces Termination of Joint Venture at the Healy Project, Alaska and Completes Top-Up Right from Sumitomo and CenterraJune 27, 2025 7:30 AM EDT | Source: Kenorland Minerals Ltd.Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) ("Kenorland" or the "Company") announces that Newmont Corporation ("Newmont") has delivered a notice to terminate the joint venture agreement in respect of the Healy project (the "P ...
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
Globenewswire· 2025-06-27 19:30
EMERYVILLE, Calif. and SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) and Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq-CM: TSBX) today announced that they have entered into a definitive merger agreement (“the Merger Agreement”), whereby XOMA Royalty will acquire Turnstone for $0.34 in cash per share of Turnstone common stock (“Turnstone common stock”) plus one non-transferable contingent value right (“CVR”). Following a thorough revi ...
Transition Metals and 1930153 ON Ltd Sell the Fostung Tungsten Property for US$5,000,000 Cash
Newsfile· 2025-06-27 19:30
Transition Metals and 1930153 ON Ltd Sell the Fostung Tungsten Property for US$5,000,000 CashJune 27, 2025 7:30 AM EDT | Source: Transition Metals Corp.Sudbury, Ontario--(Newsfile Corp. - June 27, 2025) - Transition Metals Corp. (TSXV: XTM) ("Transition" or "the Company"), together with 1930153 ON Ltd. ("1930153 ON"), a private Ontario corporation, collectively the "Vending Parties", are pleased to announce the joint sale of their respective 50% interests in the Fostung Tungsten Property ("the ...
Digital Asset Technologies Appoints Marcus Ingram as Chief Executive Officer and Director
Globenewswire· 2025-06-27 19:30
VANCOUVER, BC, June 27, 2025 (GLOBE NEWSWIRE) -- Digital Asset Technologies Inc. (CSE: DATT) (OTCPK: EATBF) (FSE: 988) (“DATT” or the “Company”), a technology focused investment issuer, is pleased to announce that Marcus Ingram, the current CEO of its wholly owned portfolio company, LiquidLink, has been appointed as the new CEO and Director of DATT. Mr. Ingram will also continue in his role as CEO of LiquidLink while taking on executive leadership across DATT’s broader portfolio and strategy. This appointme ...
被原控股股东占用资金,阳煤化工遭证监会立案调查,此前两年已亏损超20亿元
华夏时报· 2025-06-27 19:29
对于占用资金的具体细节,阳煤化工并未披露。公司回复记者,"目前上述涉及资金已全部归还。目前 公司尚未收到中国证监会关于上述立案调查事项的结论性调查意见或决定,公司高度重视信披合规,若 后续有相关进展,公司将严格依法依规履行披露义务,请关注公司公告。" 记者查询公告发现,上交所曾发布《关于阳煤化工股份有限公司2021年年度报告的信息披露监管工作 函》(下称《监管工作函》),要求公司说明是否存在未披露的关联方非经营性资金占用的情况。 上交所在《监管工作函》指出,会计师出具的专项意见显示,公司与控股股东华阳集团有限公司发生经 营性往来11.40亿元,期末余额130.03万元,形成原因系股权转让款、保证金及往来款,列报科目为其他 应收款。 日前,阳煤化工(600691.SH)发布公告称,公司于近日收到中国证券监督管理委员会下发的《立案告 知书》,因公司涉嫌未按规定披露非经营性资金往来,根据《中华人民共和国证券法》《中华人民共和 国行政处罚法》等法律法规,中国证监会决定对公司立案。 阳煤化工6月27日回复《华夏时报》记者,公司不涉及财务造假问题,中国证监会目前对公司的立案调 查事项系"涉嫌未按规定披露非经营性资金往来" ...
Plumas Bancorp(PLBC) - 2024 Q2 - Earnings Call Presentation
2025-06-27 19:29
Nevada County INVESTOR PRESENTATION UPDATED THROUGH JUNE 30, 2024 1 Forward Looking Statements Disclaimer The statements contained herein that are not historical facts are forward-looking statements based on management's current expectations and beliefs concerning future developments and their potential effects on the Company. Such statements involve inherent risks and uncertainties, many of which are difficult to predict and are generally beyond our control. There can be no assurance that future developmen ...
Plumas Bancorp(PLBC) - 2024 Q3 - Earnings Call Presentation
2025-06-27 19:28
Nevada County INVESTOR PRESENTATION UPDATED THROUGH SEPTEMBER 30, 2024 1 Forward Looking Statements Disclaimer The statements contained herein that are not historical facts are forward-looking statements based on management's current expectations and beliefs concerning future developments and their potential effects on the Company. Such statements involve inherent risks and uncertainties, many of which are difficult to predict and are generally beyond our control. There can be no assurance that future devel ...
Plumas Bancorp(PLBC) - 2024 Q4 - Earnings Call Presentation
2025-06-27 19:28
Nevada County INVESTOR PRESENTATION UPDATED THROUGH DECEMBER 31, 2024 1 Plumas County Index Forward Looking Statements Disclaimer The statements contained herein that are not historical facts are forward-looking statements based on management's current expectations and beliefs concerning future developments and their potential effects on the Company. Such statements involve inherent risks and uncertainties, many of which are difficult to predict and are generally beyond our control. There can be no assuranc ...
FOXO TECHNOLOGIES INC. DESIGNATES NEW SERIES OF PREFERRED STOCK TO BE USED FOR ACQUISITIONS
Globenewswire· 2025-06-27 19:27
WEST PALM BEACH, FLORIDA, June 27, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that it has designated a new series of its preferred stock (Series E Cumulative Redeemable Secured Preferred Stock e (the “Series E Preferred Stock”)) and filed the series’ certificate of designation with the Secretary of State of Delaware. The newly designated series of preferred stock includes: (i) a stated value of $25.00 per share, (ii) a 2.5% per annum cash ...
海王生物(000078) - 2025年6月27日投资者关系活动记录表
2025-06-27 19:26
资本结构优化 - 公司将与有意向的国资主体积极洽谈股权合作,探讨资源整合与业务协同,也考虑引入国资作为财务性投资以优化资本结构 [1][2] 医疗器械板块业务规划 - 2024 年医疗器械板块营业收入约 95.88 亿元,未来扩大器械代理纯销业务规模,向拥有外资品牌代理权企业转型,提高国产医疗器械市场占有率,资金充裕时布局制造业务并开展研发 [3] 商誉减值情况 - 2024 年对存在商誉减值迹象的子公司计提约 4.78 亿元,截至 2024 年 12 月 31 日商誉账面价值为 3.79 亿元,未来减值风险下降 [4] 并购策略 - 未来并购更审慎,不进行大规模医药商业公司并购,维持现有业务稳健经营,加速处置低效业务和非核心子公司,资金充裕时考虑布局医疗器械制造业务及战略并购 [5][6] 应收账款解决方案 - 建立以财务总监为首席责任人的管理团队,各区域集团及子公司成立清收小组,确定目标并制订奖惩办法,每季度通报执行情况并给出清收建议,积极通过诉讼清收 [7] 融资规划 - 公司属资金密集型行业,一直在探讨合适融资方式,会根据业务需求合理筹划,条件成熟时选择适合的融资工具拓宽渠道 [8] 提升利润率规划 - 提高资金使用效率,放弃低毛利业务,加大对医疗器械及工业板块投入,处置非核心子公司,发挥海王体系协同效应,参加联盟带量采购,利用零售渠道资源协同销售 [9][10] 医药流通行业格局 - 目前行业集中度有提升空间,未来集中度将持续提升,资源向头部企业集聚,小规模企业和民营企业压力增大,不少民营企业寻求与国资合作 [10]